CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 131 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | -22.2% | 10,548 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $18 | +157.1% | 10,548 | +132.7% | 0.01% | +166.7% |
| Q1 2023 | $7 | -100.0% | 4,533 | -77.3% | 0.00% | -78.6% |
| Q3 2022 | $29,000 | -21.6% | 20,000 | 0.0% | 0.01% | -17.6% |
| Q2 2022 | $37,000 | +362.5% | 20,000 | +566.7% | 0.02% | +466.7% |
| Q1 2022 | $8,000 | -33.3% | 3,000 | +115.8% | 0.00% | -40.0% |
| Q2 2020 | $12,000 | +9.1% | 1,390 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $11,000 | +37.5% | 1,390 | +42.3% | 0.01% | +100.0% |
| Q4 2019 | $8,000 | +100.0% | 977 | +81.9% | 0.00% | +50.0% |
| Q3 2019 | $4,000 | 0.0% | 537 | +48.3% | 0.00% | 0.0% |
| Q2 2019 | $4,000 | 0.0% | 362 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | -20.0% | 362 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |